Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.67M | -16.99M | -15.80M | -13.77M | -12.17M |
| Total Depreciation and Amortization | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20M | 972.20K | 931.50K | 986.60K | 1.05M |
| Change in Net Operating Assets | 2.09M | 102.40K | 1.23M | 1.94M | 323.30K |
| Cash from Operations | -15.27M | -15.82M | -13.54M | -10.74M | -10.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -593.70K | -2.93M | -4.28M | 3.81M | 3.88M |
| Cash from Investing | -593.70K | -2.93M | -4.28M | 3.81M | 3.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -600.00K | -600.00K | -600.00K | -600.00K | -600.00K |
| Issuance of Common Stock | 18.65M | 18.65M | 18.61M | 6.24M | 6.24M |
| Repurchase of Common Stock | -1.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.05M | 18.05M | 18.01M | 5.64M | 5.64M |
| Foreign Exchange rate Adjustments | -500.00 | -100.00 | -600.00 | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.18M | -697.60K | 194.80K | -1.29M | -1.18M |